DK3781172T3 - Behandling af lungebetændelse - Google Patents

Behandling af lungebetændelse Download PDF

Info

Publication number
DK3781172T3
DK3781172T3 DK19716950.1T DK19716950T DK3781172T3 DK 3781172 T3 DK3781172 T3 DK 3781172T3 DK 19716950 T DK19716950 T DK 19716950T DK 3781172 T3 DK3781172 T3 DK 3781172T3
Authority
DK
Denmark
Prior art keywords
pneumonia
treatment
Prior art date
Application number
DK19716950.1T
Other languages
English (en)
Inventor
Da Silveira Lajaunias Samareh Azeredo
Frédéric Lajaunias
Original Assignee
Combioxin Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Combioxin Sa filed Critical Combioxin Sa
Application granted granted Critical
Publication of DK3781172T3 publication Critical patent/DK3781172T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19716950.1T 2018-04-17 2019-04-16 Behandling af lungebetændelse DK3781172T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18167848 2018-04-17
PCT/EP2019/059826 WO2019201937A1 (en) 2018-04-17 2019-04-16 Treatment of pneumonia

Publications (1)

Publication Number Publication Date
DK3781172T3 true DK3781172T3 (da) 2023-10-02

Family

ID=62017276

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19716950.1T DK3781172T3 (da) 2018-04-17 2019-04-16 Behandling af lungebetændelse

Country Status (19)

Country Link
US (1) US12059496B2 (da)
EP (2) EP4338743A1 (da)
JP (2) JP7411569B2 (da)
KR (1) KR20210003117A (da)
CN (1) CN112004540A (da)
AU (1) AU2019254515A1 (da)
CA (1) CA3096968A1 (da)
DK (1) DK3781172T3 (da)
ES (1) ES2959435T3 (da)
FI (1) FI3781172T3 (da)
HR (1) HRP20231405T1 (da)
HU (1) HUE064198T2 (da)
LT (1) LT3781172T (da)
MX (1) MX2020010853A (da)
PL (1) PL3781172T3 (da)
PT (1) PT3781172T (da)
RS (1) RS64891B1 (da)
SI (1) SI3781172T1 (da)
WO (1) WO2019201937A1 (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2875470C (en) * 2012-06-14 2021-01-12 Universitaet Bern Tailored liposomes for the treatment of bacterial infections

Also Published As

Publication number Publication date
LT3781172T (lt) 2023-11-10
JP7411569B2 (ja) 2024-01-11
RS64891B1 (sr) 2023-12-29
HRP20231405T1 (hr) 2024-03-01
FI3781172T3 (fi) 2023-10-02
WO2019201937A1 (en) 2019-10-24
JP2021521191A (ja) 2021-08-26
EP3781172A1 (en) 2021-02-24
EP4338743A1 (en) 2024-03-20
PT3781172T (pt) 2023-10-11
US12059496B2 (en) 2024-08-13
EP3781172B1 (en) 2023-08-30
HUE064198T2 (hu) 2024-03-28
PL3781172T3 (pl) 2024-02-12
AU2019254515A1 (en) 2020-11-05
US20210030677A1 (en) 2021-02-04
KR20210003117A (ko) 2021-01-11
CA3096968A1 (en) 2019-10-24
SI3781172T1 (sl) 2023-11-30
JP2024023208A (ja) 2024-02-21
MX2020010853A (es) 2020-11-06
CN112004540A (zh) 2020-11-27
ES2959435T3 (es) 2024-02-26

Similar Documents

Publication Publication Date Title
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3554240T3 (da) Kombinationer af aktive forbindelser
DK3851537T5 (da) Behandling af hyperbilirubinæmi
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
DK3458052T3 (da) Kombinationsbehandling af cancer
DK3512857T3 (da) Spiro-bicykliske inhibitorer af menin-mll-interaktion
DK3457851T3 (da) Derivater af sobetirom
DK3307267T3 (da) Behandling af multipel sklerose
DK3506904T3 (da) Behandling af demens
DK3436074T3 (da) Thiazolidforbindelser til behandling af virale infektioner
DK3793960T3 (da) Kalkmælk
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation
DK3532076T3 (da) Immunterapeutiske behandlinger af tumorer
DK3500875T3 (da) Begrænsning af dithering af kildeaktiveringer
IT201700028116A1 (it) Gruppo di attuazione rotativo-lineare
DK3529236T3 (da) Krystalformer af eravacyclin
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
DK2897382T3 (da) Forbedring af binaural kilde
DK3759745T3 (da) Dannelse af piezoelektriske anordninger
DK3678644T3 (da) Formuleringer af copanlisib
DK3743064T3 (da) Behandling af proteinuri
DK3856213T3 (da) Fremgangsmåder til behandling af infektioner under anvendelse af bakterier
DK3430004T3 (da) Faststofformer af nilotinibsalte
DK3597167T3 (da) Nedbrydning af kropsrester